【摘要】 目的评价流变溶栓序贯治疗门脉系静脉血栓形成的临床疗效。方法11例门脉系静脉血栓形成病例经流变溶栓序贯治疗,包括血管腔内成形术、内支架植入术进行门静脉开通治疗,观察门静脉再通、临床症状缓解和并发症发生情况。结果10例开通成功,开通率90.9%。整个流变溶栓过程所需时间<30 m in,5例溶栓后对基础狭窄行经皮血管腔内成形术,2例行内支架治疗,无并发症发生,随访5~14个月,均生存无复发。结论流变溶栓治疗门静脉系血栓形成具有损伤小、溶栓能力强的特点;结合序贯治疗方案,则更加合理,治疗效果更明确、持久。更多还原

【Abstract】 Objective To evaluate the efficacy of the sequential rheolytic thrombectomy catheter(Hydrolyser) method in treatment of portal venous thrombosis. Methods Thrombolytic therapy was performed by urokinase and percutaneous transhepatic rheolytic thrombectomy with percutaneous transluminal angioplasty(PTA) or stents placement in 11 patients with portal venous thrombosis.The recanalization of portal veins and relative clinical symptoms and complications were observed. Results Technical success was attained in 10 patients.The technical success rate was 90.9%.The time of Hydrolyser course was <30 min.The underlying stenosis was treated with PTA in 5 cases and one stent was placed in 2 cases.There were no complications.Follow-up time was 5~14 months.All cases,the portal veins have been remained patency or partly patency. Conclusion Hydrolyser for treatment of portal venous thrombosis has mini-traumatic and high performance characteristics.Combing with sequential method,it will be more reasonable and efficiency for portal venous thrombosis.更多还原